Two papers presented at the recent American Society of Clinical Oncology (ASCO) have brought to light to potential serious drug interaction between tamoxifen and several commonly used SSRI antidepressants.
The FDA has approved prasugrel, a new oral antiplatelet agent for use in preventing thrombosis in patients with acute coronary syndrome who are to be managed by angioplasty.
The anti-arrhythmic dronedarone has been approved by the FDA for maintenance of normal sinus rhythm in patients with a history of atrial fibrillation or atrial flutter.
The FDA has recently issued stronger warnings on a number of commonly used drugs:
Hand trauma is common, and children frequently present to the emergency department (ED) with these injuries.
Emergency medicine physicians routinely deal with cardiac emergencies in adult patients but rarely encounter infants with critical cardiac conditions. While the infant's cardiac physiology can be very different from an adult's, the general principles of preload, afterload, contractility, and vascular resistance are the same.
